Introduction of QUASAR GRID3D Advantage
IBA (Ion Beam Applications S.A.) recently unveiled its innovative QUASAR GRID3D Advantage Image Distortion Analysis System. This launch marks a significant advancement in the realm of MR-guided radiation therapy and MR simulation in planning, showcased at a prestigious industry event in Europe.
The Significance of Accurate MR Imaging
Magnetic Resonance Imaging (MRI) is increasingly vital in radiation therapy, offering exceptional soft tissue contrast without the exposure to ionizing radiation. This quality is essential for accurately targeting tumors while sparing healthy surrounding tissues. However, geometrical distortions in MR images can hinder treatment precision. Thus, effective quality assurance tools are critical to maintaining image fidelity, which is where the GRID3D Advantage comes in.
Highlights of GRID3D Advantage
The QUASAR GRID3D Advantage is ingeniously designed for medical facilities that require meticulous distortion analysis for stereotactic planning. It features user-friendly software and is equipped to work with various frame adapters, providing flexibility in its application.
Industry Leaders Speak
Industry experts are excited about this development. Ian Paddick, a director at a leading medical physics firm, remarked that the new system serves as the gold standard for measuring image distortion. Its utility for the Vantage Frame setup marks a pivotal improvement in the quality assurance landscape for Gamma Knife radiosurgery.
Comments from IBA Leadership
Jean-Marc Bothy, President of IBA Dosimetry, emphasized the necessity of precise geometric distortion QA, particularly in small field cases where small inaccuracies can influence treatment outcomes. He highlighted that the GRID3D Advantage is a testament to IBA's commitment to enhancing the precision and reliability of MRI geometric distortion evaluations.
About IBA
Established as a frontrunner in particle accelerator technology, IBA is renowned for its provision of the most sophisticated radiation therapy alternatives available, particularly proton therapy. This advanced form of treatment is complemented by IBA's offerings in industrial sterilization, radiopharmaceuticals, and dosimetry. The company, headquartered in Louvain-la-Neuve, boasts a workforce of approximately 2,100 individuals across the globe and is recognized as a certified B Corporation, adhering to exemplary social and environmental standards.
With a listing on the EURONEXT exchange under the ticker symbol IBAB, IBA continues to advance the frontiers of medical technology and patient care.
Frequently Asked Questions
What is the QUASAR GRID3D Advantage System?
The QUASAR GRID3D Advantage is an innovative system designed to accurately analyze image distortion for MR-guided radiation therapy, enhancing treatment precision.
Why is accurate MR imaging important in radiation therapy?
Accurate MR imaging is crucial for precisely targeting tumors while protecting surrounding healthy tissue from radiation damage.
How does GRID3D Advantage improve quality assurance?
It combines automated analysis with user-friendly software and various attachments, ensuring comprehensive evaluation of MR image fidelity.
What does IBA specialize in?
IBA specializes in particle accelerator technology, notably in proton therapy, industrial sterilization, radiopharmaceuticals, and dosimetry solutions.
What is IBA's commitment as a B Corporation?
As a certified B Corporation, IBA is dedicated to meeting high social and environmental performance standards while delivering innovative healthcare solutions.
